ARTICLE | Clinical News

MIV-711: Ph IIa MIV-711-201 ongoing

December 9, 2016 12:03 AM UTC

An IDMC recommended continuation for the third time the double-blind, placebo-controlled, European Phase IIa MIV-711-201 trial of oral MIV-711 based on safety data from the first 150 patients with kne...

BCIQ Company Profiles

Medivir AB

BCIQ Target Profiles

Cathepsin K (CTSK)